Biomarker expansion positions CRO for rapid growth; Edison
Niche CRO Proteome Sciences is poised for triple-digit sales growth as its biomarker business takes off, an investment research firm said.
Archives for April 3, 2012
FDA welcomes joiners to API regulatory sharing scheme
The FDA says it expects more boards to join an inter-regulatory API (active pharmaceutical ingredient) inspection programme after simplifying the sign-up process.
IPEC Fed says drugmaker requests for metal impurity data are premature
Drugmakers should not ask excipient suppliers for metal impurity data until exposure limits are agreed according to industry group IPEC Federation.
Catalent eyes emerging market expansion of end-to-end development service model
Catalent wants to build on its European expansions by replicating the end-to-end drug development services model in emerging markets.
FDA finds more counterfeit Roche oncology drugs in US
The FDA has found counterfeits of a Roche oncology drug in US medical practices six weeks after the discovery of fake Avastin.
News from Lonza, Agilux and Chiltern – People on the move
Outsourcing-Pharma presents its weekly round-up of the latest changes on the pharmaceutical jobs ladder including news from Lonza, Agilux and Chiltern.